CME Information

Activity Overview/Description

This three-day live meeting will feature dynamic and enriching sessions and panel discussion on topics that include the 340B Program, the role of the Federal Government in achieving health equity, the Black vote, and organizational collaborations to advance health equity.

Target Audience

This activity is intended for Physicians, Physician Assistants, Podiatrists, and Nurse Assistants.

Accreditation Statement: The National Medical Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement

The National Medical Association designates this live in-person activity for a maximum of 16 PAMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Learning Objectives

  • Describe the current National 340B Program Review the pros of the current National 340B Program.
  • Evaluate the role of the Federal government in achieving health equity.
  • Determine the role of nutrition in reducing chronic disease.
  • Review S. 2821/H.R. 1826 – Prostate-Specific Antigen Screening for High-Risk Insured Men Act.
  • Assess how the Black vote can help eliminate health disparities.
  • Examine why Diversity, Equity and Inclusion (DEI) Matters.

Unapproved Use of Disclosure

Please note that this activity may contain discussions of unlabeled uses of FDA-approved products, AND/ OR discussions of investigational products not yet approved by the FDA. Please refer to the official prescribing information for approved indications, contraindications, and warnings.

Summary of Planning/Faculty Disclosure

In accordance with the ACCME’s Standards for Integrity and Independence, all persons who control the educational content of NMA accredited activities must disclose all financial relationships with any ineligible companies that they have had over the past 24 months. NMA uses the ACCME’s definition of ineligible companies: Those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. There is no minimum financial threshold. NMA determines whether any of these relationships is relevant to this activity. All the relevant financial relationships identified for persons in a position to control activity content have been mitigated.

The following planners, moderators, and speakers declare no relevant relationship with commercial entities.

  • Mr. Wiley Adams
  • Jacqueline Ayers
  • Desmond Banks, Ph.D., M.P.H.
  • Ayanna Bennett, M.D., MSPH
  • Aliya Bhatia
  • Sharon L. Bethea, Ph.D
  • Desmond Banks, Ph.D
  • Maria Bright
  • DeAndrea Bullock, P.T., D.P.T., C.C.I.
  • Dr. Ebony Caldwell
  • Joy D. Calloway, M.B.A., MHSA
  • Rep. Troy A. Carter, Sr.
  • Nicole Cheek, D.D.S.
  • Chris Cox
  • Phyllis Dickerson
  • Janet De Jesus, M.S., R.D.
  • Pebbles Fagan, Ph.D., M.P.H.
  • Maj. Gen (ret) Paul Friedrichs, M.D.
  • Kyler Gilkey
  • Brian Greer
  • Mignonne Guy, Ph.D.
  • Justine Handleman
  • Leah Hill
  • Tony Jackson, Pharm.D., M.B.A.
  • *Derrick Johnson
  • Thomas Johnson
  • Vacheria Keys, J.D.
  • Iyanla Kollock
  • Yolanda Lawson, M.D.
  • Yvens Laborde, M.D.
  • Christine S. Lee, Pharm.D., Ph.D.
  • Leandris Liburd, Ph.D., M.P.H., M.A.
  • Dr. Lisa Mallory
  • Roland Martin
  • Thomas Mason, M.D.
  • Aletha Maybank, M.D., M.P.H.
  • Ja’Nia McPhatter
  • Keesha M. Middlemass, Ph.D.
  • Vice Admiral Vivek H. Murthy, M.D., M.B.A.
  • Frank North, Pharm.D., M.P.A.
  • Pilar Ortega, M.D., M.G.M.
  • Councilman Zachary Parker
  • Hon. Eliseo J. Pérez-Stable, M.D.
  • Renata Rawlings-Goss, Ph.D.
  • Kenny Ray
  • Walter Rayford, Ph.D., M.D., M.B.A.
  • Janet Reid-Hector, Ed.D., R.D.
  • Kenneth Schell, Pharm.D., R.Ph., CIPP
  • Sakeenah Shabazz
  • Bruce Siegel, M.D., M.P.H.
  • Brian D. Smedley, Ph.D.
  • Kymberle Landrum Sterling, Dr.P.H.
  • Brad L. Stewart
  • Dr. John H. Stewart
  • Eve Stoody, Ph.D.
  • Maureen Testoni, J.D.
  • Danielle Turnipseed, J.D., MHSA, M.P.P.
  • Willie Underwood, III, M.D., M.Sc., M.P.H.
  • Maranda C. Ward, Ed.D., M.P.H.
  • Victoria (Tori) Wenger, J.D.
  • Hon. Robert C. White, Jr.
  • James M. Williams, Jr.
  • Mike Ybarra, M.D.

The following planners, moderators, and speakers declare the following relations with commercial entities.

  • Marie L. Borum, M.D., Ed.D., M.P.H.: Takeda Pharmaceuticals – Consultant
  • Dr. Sheldon D. Fields: Pfizer/Gilead – Consultant

Note: *Indicates disclosure not submitted at time of printing


National Medical Association and their staff are not responsible for injury or illness resulting from the use of medications or modalities discussed during this educational activity. The information provided at this CME activity is for continuing education purposes only and is not meant to substitute for the independent medical judgement of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition.

Instructions to Receive Credit

Participants must view the CME materials, attend the live activity and complete and submit the evaluation and return the completed CME Credit Attestation form.

NMA would like to thank the following sponsors for their support of the NMA 2024 Colloquium.